BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2
BARDA is collaborating with Hememics Biotechnologies, Inc. on the development of a rapid, Bluetooth-connected SARS-CoV-2 diagnostic test. The test is ...
Tag: Current Edition
BARDA and Sanofi Prepare for Studies of COVID-19 Vaccine
BARDA and Sanofi Pasteur, the vaccines global business unit of Sanofi, are expanding their collaboration to develop a SARS-CoV-2 vaccine. ...
FDA Accepts for Priority Review for REGN-EB3 to Treat Ebola
Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a new ...
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets
Abbott announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the ...
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19
BARDA and Vela Diagnostics USA, Inc. are entering into a partnership to develop a rapid diagnostic test for use on ...
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19
Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available antiviral compound, ...
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections
BARDA is collaborating with DiaSorin to develop a clinical laboratory test to identify people who have been infected with the ...
Lilly Begins Clinical Testing of Therapies for COVID-19
Eli Lilly announced it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part ...
Rapid Lab-Free PCR COVID-19 Test in Development by DnaNudge and Imperial College
The Lab-in-Cartridge rapid test, based on Professor Toumazou’s DnaNudge consumer DNA testing innovation, has been clinically validated after a successful ...
DuPont to Produce up to 4.5 Million TYVEK Protective Suits for U.S. Healthcare Workers
The U.S. Department of Health and Human Services (HHS) announced an agreement with DuPont to expedite the delivery of critical ...
HHS Announces Ventilator Contract with Philips under Defense Production Act
The Department of Health and Human Services announced the second contract for ventilator production rated under the Defense Production Act ...
Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche
Arrakis Therapeutics, a biopharmaceutical company working on the discovery of a new class of small molecule medicines that directly target ...
BARDA Funds Nanomix to Develop Rapid Mobile COVID-19 Diagnostics
BARDA has partnered with Nanomix, Inc. on the development of a COVID-19 rapid mobile test to diagnose COVID-19 infections with ...
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19
Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned by Emory ...
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate
INOVIO Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has accepted the company's Investigational New Drug (IND) ...
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment
BARDA expanded an existing partnership with Genentech, part of Roche Group and headquartered in South San Francisco, to accelerate a Phase ...
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19
Amgen and Adaptive Biotechnologies announced a collaboration aimed at combing expertise to discover and develop fully human neutralizing antibodies targeting ...
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19
Emergent BioSolutions Inc. announced today that it has entered into a formal partnership with the U.S. government to expedite development of a ...
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy
Celularity Inc., a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration ...
